HomeCompareSDGCF vs JNJ

SDGCF vs JNJ: Dividend Comparison 2026

SDGCF yields 3.09% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SDGCF wins by $17.90M in total portfolio value
10 years
SDGCF
SDGCF
● Live price
3.09%
Share price
$28.18
Annual div
$0.87
5Y div CAGR
81.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17.93M
Annual income
$15,377,356.42
Full SDGCF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SDGCF vs JNJ

📍 SDGCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSDGCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SDGCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SDGCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SDGCF
Annual income on $10K today (after 15% tax)
$262.70/yr
After 10yr DRIP, annual income (after tax)
$13,070,752.96/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SDGCF beats the other by $13,066,766.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SDGCF + JNJ for your $10,000?

SDGCF: 50%JNJ: 50%
100% JNJ50/50100% SDGCF
Portfolio after 10yr
$8.98M
Annual income
$7,691,022.91/yr
Blended yield
85.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SDGCF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
4.8
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SDGCF buys
0
JNJ buys
0
No recent congressional trades found for SDGCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSDGCFJNJ
Forward yield3.09%2.13%
Annual dividend / share$0.87$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR81.3%28%
Portfolio after 10y$17.93M$30.3K
Annual income after 10y$15,377,356.42$4,689.40
Total dividends collected$17.70M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: SDGCF vs JNJ ($10,000, DRIP)

YearSDGCF PortfolioSDGCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,260$560.33$10,592$272.30+$668.00SDGCF
2$13,118$1,069.08$11,289$357.73+$1.8KSDGCF
3$16,146$2,110.22$12,123$472.89+$4.0KSDGCF
4$21,677$4,401.03$13,141$629.86+$8.5KSDGCF
5$33,206$10,011.69$14,408$846.81+$18.8KSDGCF
6$61,517$25,985.90$16,021$1,151.60+$45.5KSDGCF
7$147,392$81,568.60$18,122$1,588.22+$129.3KSDGCF
8$488,852$331,143.27$20,930$2,228.20+$467.9KSDGCF
9$2,384,023$1,860,950.80$24,792$3,191.91+$2.36MSDGCF
10$17,928,261$15,377,356.42$30,274$4,689.40+$17.90MSDGCF

SDGCF vs JNJ: Complete Analysis 2026

SDGCFStock

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.

Full SDGCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SDGCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SDGCF vs SCHDSDGCF vs JEPISDGCF vs OSDGCF vs KOSDGCF vs MAINSDGCF vs ABBVSDGCF vs MRKSDGCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.